Trulieve Cannabis is trading 5.5% up at $11.71 on November 3 after the company announced it received DEA registrations for state-licensed medical marijuana dispensaries.
- The November 2 announcement was part of the initial rollout under the new framework for qualifying medical cannabis operations.
- Shares gained 7.98% at the November 2 close.
- November 3 coverage continued to cite the registrations; mixed broader-market moves do not appear to be the primary explanation.